Ion Agirrezabal
Bonn, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Cost comparison of efanesoctocog alfa vs conventional factor VIII therapies for major surgeries in patients with severe hemophilia A.
Journal: Blood vessels, thrombosis & hemostasis
Published: December 24, 2025
Author's Reply to Perera et al.: A Commentary on "An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom".
Journal: Clinical drug investigation
Published: April 09, 2025
Cost Effectiveness of Efanesoctocog Alfa Versus Factor VIII Extended Half-Life in Adolescent and Adult Patients with Hemophilia A in the USA.
Journal: PharmacoEconomics
Published: February 11, 2025
Association of adverse events and quality of life in patients with unresectable hepatocellular carcinoma.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: August 30, 2024
Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial.
Journal: Journal of patient-reported outcomes
Published: August 21, 2024
An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom.
Journal: Clinical drug investigation
Published: April 25, 2024
Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis.
Journal: Advances in therapy
Published: November 08, 2023
Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 21, 2023
Cost-effectiveness of selective internal radiation therapy with Y-90 resin microspheres for intermediate- and advanced-stage hepatocellular carcinoma in Brazil.
Journal: Journal of medical economics
Published: May 04, 2023
Advances in Delivery of Selective Internal Radiation Therapy (SIRT): Economic and Logistical Effects of Same-Stay Work-Up and Procedure in the Treatment of Unresectable Liver Tumors in England.
Journal: Advances in therapy
Published: August 03, 2022
Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life.
Journal: Advances in therapy
Published: January 03, 2022
Patient preferences for advanced hepatocellular carcinoma treatment: a multicountry stated preference study.
Journal: Future oncology (London, England)
Published: July 27, 2021
Last Updated: 09/26/2026